Evidence map›Paper›PMID 40832254›Full record

ArticlebioRxiv : the preprint server for biology2025

fSuSiE enables fine-mapping of QTLs from genome-scale molecular profiles.

William R P Denault, Hao Sun, Peter Carbonetto, Anjing Liu, Philip L De Jager, David Bennett, Alzheimer's Disease Functional Genomics Consortium, Gao Wang, Matthew Stephens

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

William R P DenaultDepartment of Human Genetics, University of Chicago, Chicago, IL, USA.
Hao SunCenter for Statistical Genetics, The Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA.
Peter CarbonettoDepartment of Human Genetics, University of Chicago, Chicago, IL, USA.
Anjing LiuCenter for Statistical Genetics, The Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA.
Philip L De JagerCenter for Translational & Computational Neuroimmunology, Columbia University, New York, NY, USA.
David BennettRush Alzheimer's Disease Center and Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA.
Alzheimer's Disease Functional Genomics Consortium
Gao WangCenter for Statistical Genetics, The Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA.
Matthew StephensDepartment of Human Genetics, University of Chicago, Chicago, IL, USA.

Funding

Genome analysis: statistical methods and applicationsR01HG002585 · NHGRI · UNIVERSITY OF WASHINGTON · PI MATTHEW STEPHENS · 2002 to 2026
$8.4M
FunGen-xQTL: Unraveling the genetic basis of molecular functions in Alzheimer's DiseaseR01AG086467 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Julia TCW, Gao Wang · 2025 to 2026
$7.2M
Multiomics data integration methods to discover putative causal variants, genes and patient heterogeneity for Alzheimers diseaseR01AG076901 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Gao Wang · 2023 to 2026
$2.4M
Computational genomics approaches to study mechanisms and function of mRNA splicingR35GM153249 · NIGMS · UNIVERSITY OF CHICAGO · PI Yang Li · 2024 to 2026
$1.2M
NHGRI NIH HHS R01 HG002585NIA NIH HHS R01 AG076901NIA NIH HHS R01 AG086467NIGMS NIH HHS R35 GM153249
6 · The paper itself

Abstract

Molecular quantitative trait locus (QTL) studies seek to identify the causal variants affecting molecular traits like DNA methylation and histone modifications. However, existing fine-mapping tools are not well suited to molecular traits, and so molecular QTL analyses typically proceed by considering each variant and each molecular measurement independently, ignoring the LD among variants and the spatial correlation in effects between nearby sites. This severely limits accuracy in identifying causal variants and quantifying their molecular trait effects. Here, we introduce fSuSiE ("functional Sum of Single Effects"), a fine-mapping method that addresses these challenges by explicitly modeling the spatial structure of genetic effects on molecular traits. fSuSiE integrates wavelet-based functional regression with the computationally efficient "Sum of Single Effects" framework to simultaneously finemap causal variants and identify the molecular traits they affect. In simulations, fSuSiE identified causal variants and affected CpGs more accurately than methods that ignore spatial structure. In applications to DNA methylation and histone acetylation (H3K9ac) data from the ROSMAP study of the dorsolateral prefrontal cortex, fSuSiE achieved dramatically higher resolution than existing methods (e.g., identifying 6,355 single-variant methylation credible sets compared to only 328 from an existing approach). Applied to Alzheimer's disease (AD) risk loci, fSuSiE identified potential causal variants colocalizing with AD GWAS signals for established genes, including

Identifiers

PMID40832254
PMCPMC12363973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.